RSS 1.0Family Physicians Inquiries Network (MU)
The Family Physicians Inquiries Network is a community of inclusion that is committed to engaging every organization and individual who wishes to join us in revolutionizing primary care practice. The primary focus of the network is developing valuable benefits for family medicine departments, family practice residency programs and medical librarians/health sciences libraries.
Items in MOspace are protected by copyright, with all rights reserved, unless otherwise indicated.
Sub-communities within this community
Recent Submissions
-
Should you switch the DAPT agent one month after ACS?
(Family Physicians Inquiries Network, 2019-04)Should you switch the DAPT agent one month after ACS? A randomized controlled trial says “Yes,” but current guidelines say “No.” PRACTICE CHANGER: Switch to clopidogrel from one of the newer P2Y12 blockers 1 ... -
What are the risks of long-term PPI use for GERD symptoms in patients > 65 years?
(2019-04)Q: What are the risks of long-term PPI for GERD symptoms in patients > 65 years? EVIDENCE-BASED ANSWER: THE USE OF PROTON PUMP INHIBITORS (PPIs) to control gastrointestinal esophageal reflux disease (GRED) is significantly ... -
Bariatric surgery plus medical therapy : effective Tx for T2DM?
(Family Physicians Inquiries Network, 2019-03)Bariatric surgery + medical therapy: Effective Tx for T2DM? Short-term studies have indicated “Yes,” but does a longterm randomized controlled trial give it a thumbs up? PRACTICE CHANGER: Consider bariatric surgery with ... -
How do these 3 diabetes agents compare in reducing mortality?
(Family Physicians Inquiries Network, 2019-03)How do these 3 diabetes agents compare in reducing mortality? A meta-analysis reveals that there may be advantages associated with SGLT-2 inhibitors and GLP-1 agonists that are not associated with DPP-4 inhibitors. PRACTICE ... -
Is intra-articular platelet-rich plasma injection an effective treatment for knee OA?
(2019-03)Q: Is intra-articular platelet-rich plasma injection an effective treatment for knee OA? EVIDENCE-BASED ANSWER: PROBABLY NOT, based on the balance of evidence. While low-quality evidence may suggest potential benefit, the ... -
Does left atrial appendage closure reduce stroke rates as well as oral anticoagulants and antiplatelet meds in A-fib patients?
(2019-01)Q: Does left atrial appendage closure reduce stroke rates as well as oral anticoagulants and antiplatelet meds in A-fib patients? EVIDENCE-BASED ANSWER: Yes. Left atrial appendage closure (LAAC) with the Watchman device ... -
Less is more when it comes to ketorolac for pain
(Family Physicians Inquiries Network, 2019-02)Less is more when it comes to ketorolac for pain. It’s time to review our dosing with ketorolac for acute pain management. PRACTICE CHANGER: Using a low dose (10 mg) of intravenous ketorolac for moderate to severe acute ... -
What’s the best treatment setting for stable PE patients?
(Family Physicians Inquiries Network, 2018-12)What’s the best treatment setting for stable PE patients? The answer seems to be the outpatient setting. Here’s why. PRACTICE CHANGER: Manage patients with acute pulmonary embolism (PE) who are hemodynamically stable in ... -
Does amniotomy shorten spontaneous labor or improve outcomes?
(2018-12)Q: Does amniotomy shorten spontaneous labor or improve outcomes? Evidence-based answer: No. Amniotomy neither shortens spontaneous labor nor improves any of the following outcomes: length of first stage of labor, cesarean ... -
Should you reassess your patient’s asthma diagnosis?
(Family Physicians Inquiries Network, 2018-11)Should you reassess your patient's asthma diagnosis? Asthma may not be a permanent diagnosis in adults. A study finds that up to one-third of adults with physician-diagnosed asthma no longer had it after 5 years. ... -
Time to stop glucosamine and chondroitin for knee OA?
(Family Physicians Inquiries Network, 2018-09)Time to stop glucosamine and chondroitin for knee OA? Prior studies provided conflicting results regarding the efficacy of these medications. This study offers evidence for discontinuing them. Practice changer: Tell patients ... -
Time to switch to nonsterile gloves for these procedures?
(Family Physicians Inquiries Network, 2018-08)Time to switch to nonsterile gloves for these procedures? Are sterile gloves worth the extra cost for common cutaneous surgeries? This systematic review and meta-analysis provides answers. Practice changer: Using nonsterile ... -
First-time, mild diverticulitis: Antibiotics or watchful waiting?
(Family Physicians Inquiries Network, 2018-07)First-time, mild diverticulitis: antibiotics or watchful waiting? Dn't jump to antibiotic Tx for mild, uncomplicated diverticulitis, a recent RCT says. Observation may be just as effective. Practice changer: For mild, ... -
Let low-risk moms eat during labor?
(Family Physicians Inquiries Network, 2018-06)Let low-risk moms eat during labor? Allowing low-risk pregnant women to eat less restrictive diets during labor may not only make them happier, but may shorten labor, too. Practice changer: Allowing low-risk patients ... -
What medical therapies work for gastroparesis?
(2018-11)Q: What medical therapies work for gastroparesis? Evidence-based answer: It’s unclear if there are any highly effective medications for gastroparesis (TABLE1-10). Metoclopramide improves the sense of fullness by about 40% ... -
What’s the best VTE treatment for patients with cancer?
(2018-10)Q: What’s the best VTE treatment for patients with cancer? Evidence-based answer: No. Head-to-head studies directly compare all the main treatments for venous thromboembolism (VTE) in cancer patients. Long-term treatment ... -
How effectively do ACE inhibitors and ARBs prevent migraines?
(2018-10)Q: How effectively do ACE inhibitors and ARBs prevent migraines? Evidence-based answer: The angiotensin-converting enzyme (ACE) inhibitor lisinopril reduces the number of migraines by about 1.5 per month in patients ... -
Do statins alter the risk or progression of dementia?
(2018-09)Q: Do statins alter the risk or progression of dementia? Evidence-based answer: No. Moderate-intensity statin therapy (with pravastatin or simvastatin) doesn’t prevent progression to dementia in patients at increased risk. ... -
How often does long-term PPI therapy cause clinically significant hypomagnesemia?
(2018-09)Q: How often does long-term PPI therapy cause clinically significant hypomagnesemia? EVIDENCE-BASED ANSWER: Rarely. Proton pump inhibitors (PPIs) may be associated with decreases in serum magnesium laboratory values to ... -
What’s the best secondary treatment for patients who fail initial triple therapy for H pylori?
(2018-08)Q: What’s the best secondary treatment for patients who fail initial triple therapy for H pylori? Evidence-based answer: treating patients with Helicobacter pylori infection who have failed clarithromycin-based triple ...